Considering the innovative therapeutic approaches to activate NK anti-tumor activity, Morgana overexpression may represent an important biomarker to direct clinical intervention towards the blockage of NK inhibitory receptors39, 52. This evidence concerns the gene CHORDC1 and neoplasm.